Coeptis Therapeutics Inc. (COEP)
NASDAQ: COEP
· Real-Time Price · USD
15.38
0.38 (2.53%)
At close: Oct 17, 2025, 3:59 PM
15.38
0.00%
After-hours: Oct 17, 2025, 04:10 PM EDT
Coeptis Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | n/a | n/a | n/a | 75K |
Cost of Revenue | 1.04M | 1M | 1M | n/a |
Gross Profit | -1.04M | -1M | -1M | -372K |
Operating Income | -10.05M | -21.49M | -34.2M | -14.05M |
Interest Income | n/a | n/a | n/a | n/a |
Pretax Income | -10.88M | -21.27M | -37.57M | -13.45M |
Net Income | -9.81M | -21.27M | -37.57M | -13.45M |
Selling & General & Admin | 945.64K | 13.82M | 33.17M | 14.12M |
Research & Development | 2.33M | 6.67M | 20.89K | n/a |
Other Expenses | 6.78M | n/a | n/a | n/a |
Operating Expenses | 10.05M | 20.49M | 33.2M | 14.12M |
Interest Expense | 396.12K | -108K | 218.41K | 187.13K |
Selling & Marketing Expenses | n/a | 12.71K | 8.33K | 2.92K |
Cost & Expenses | 10.05M | 21.49M | 34.2M | 14.12M |
Income Tax Expense | -1.06M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.93M | 25.69M | 14.3M | 1.02M |
Shares Outstanding (Diluted) | 1.93M | 25.69M | 14.3M | 1.02M |
EPS (Basic) | -5.65 | -0.83 | -2.87 | -13.16 |
EPS (Diluted) | -5.65 | -0.83 | -2.87 | -13.16 |
EBITDA | -9.44M | -20.16M | -36.35M | -12.81M |
EBIT | -10.48M | -21.16M | -37.36M | -13.26M |
Depreciation & Amortization | 1.04M | 1M | 1M | 447.41K |
Source: Financial Modeling Prep. Financial Sources.